These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3553277)

  • 1. Comparison of inhaled albuterol powder and aerosol in asthma.
    Bronsky E; Bucholtz GA; Busse WW; Chervinsky P; Condemi J; Ghafouri MA; Hudson L; Lakshminarayan S; Lockey R; Reese ME
    J Allergy Clin Immunol; 1987 May; 79(5):741-7. PubMed ID: 3553277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Albuterol treatment for children with asthma: a comparison of inhaled powder and aerosol.
    Kemp JP; Furukawa CT; Bronsky EA; Grossman J; Lemanske RF; Mansfield LE; Murphy S; Ratner PH; Reese ME; Rogenes PR
    J Allergy Clin Immunol; 1989 Mar; 83(3):697-702. PubMed ID: 2647819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol.
    Blake K; Pearlman DS; Scott C; Wang Y; Stahl E; Arledge T
    Ann Allergy Asthma Immunol; 1999 Feb; 82(2):205-11. PubMed ID: 10071526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of powder and aerosol formulations of salmeterol in the treatment of asthma.
    Wolfe J; Kreitzer S; Chervinsky P; Lawrence M; Wang Y; Reilly D; Davis S; Stahl E
    Ann Allergy Asthma Immunol; 2000 Mar; 84(3):334-40. PubMed ID: 10752919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot study of bronchodilator response to inhaled albuterol delivered by metered-dose inhaler and a novel dry powder inhaler.
    Kemp JP; Hill MR; Vaughan LM; Meltzer EO; Welch MJ; Ostrom NK
    Ann Allergy Asthma Immunol; 1997 Oct; 79(4):322-6. PubMed ID: 9357377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Albuterol aerosol versus albuterol Rotacaps in exercise-induced bronchospasm in children.
    Bronsky EA; Spector SL; Pearlman DS; Justus SE; Bishop AL
    J Asthma; 1995; 32(3):207-14. PubMed ID: 7759460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Albuterol (Salbuterol) Multi-dose Dry-Powder Inhaler and ProAir(®) Hydrofluoroalkane for the Treatment of Persistent Asthma: Results of Two Randomized Double-Blind Studies.
    Kerwin EM; Taveras H; Iverson H; Wayne D; Shah T; Lepore MS; Miller DS
    Clin Drug Investig; 2016 Jan; 36(1):55-65. PubMed ID: 26541599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy and safety of twice daily fluticasone propionate powder versus placebo in the treatment of moderate asthma.
    Pearlman DS; Noonan MJ; Tashkin DP; Goldstein MF; Hamedani AG; Kellerman DJ; Schaberg A
    Ann Allergy Asthma Immunol; 1997 Apr; 78(4):356-62. PubMed ID: 9109702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term comparison of salbutamol powder with salbutamol aerosol in asthmatic out-patients.
    Hartley JP; Nogrady SG; Seaton A
    Br J Dis Chest; 1979 Jul; 73(3):271-6. PubMed ID: 399858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study.
    Busse W; Levine B; Andriano K; Lavecchia C; Yegen U
    Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular safety of high doses of inhaled fenoterol and albuterol in acute severe asthma.
    Newhouse MT; Chapman KR; McCallum AL; Abboud RT; Bowie DM; Hodder RV; Paré PD; Mesic-Fuchs H; Molfino NA
    Chest; 1996 Sep; 110(3):595-603. PubMed ID: 8797398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of acute severe asthma with inhaled albuterol delivered via jet nebulizer, metered dose inhaler with spacer, or dry powder.
    Raimondi AC; Schottlender J; Lombardi D; Molfino NA
    Chest; 1997 Jul; 112(1):24-8. PubMed ID: 9228352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled albuterol powder for the treatment of asthma--a dose-response study.
    Orgel HA; Meltzer EO; Welch MJ; Kemp JP
    J Allergy Clin Immunol; 1985 Apr; 75(4):468-71. PubMed ID: 3884688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Albuterol multidose dry powder inhaler efficacy and safety versus placebo in children with asthma.
    LaForce C; Taveras H; Iverson H; Shore P
    Allergy Asthma Proc; 2017 Jan; 38(1):28-37. PubMed ID: 28052799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical equivalence of a novel multiple dose powder inhaler versus a conventional metered dose inhaler on bronchodilating effects of salbutamol.
    Vidgren M; Silvasti M; Korhonen P; Kinkelin A; Frischer B; Stern K
    Arzneimittelforschung; 1995 Jan; 45(1):44-7. PubMed ID: 7893268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients with persistent asthma.
    Condemi JJ; Chervinsky P; Goldstein MF; Ford LB; Berger WE; Ayars GH; Rogenes PR; Edwards L; Pepsin PJ
    J Allergy Clin Immunol; 1997 Oct; 100(4):467-74. PubMed ID: 9338539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twelve- and 52-week safety of albuterol multidose dry powder inhaler in patients with persistent asthma.
    Raphael G; Taveras H; Iverson H; O'Brien C; Miller D
    J Asthma; 2016; 53(2):187-93. PubMed ID: 26369589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term efficacy and safety of fluticasone propionate powder administered once or twice daily via inhaler to patients with moderate asthma.
    ZuWallack R; Adelglass J; Clifford DP; Duke SP; Wire PD; Faris M; Harding SM
    Chest; 2000 Aug; 118(2):303-12. PubMed ID: 10936117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy.
    Fish JE; Israel E; Murray JJ; Emmett A; Boone R; Yancey SW; Rickard KA
    Chest; 2001 Aug; 120(2):423-30. PubMed ID: 11502639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.